artículo académico

• Scaled average bioequivalence methods for highly variable drugs: Leveling-off soft limits and the EMA's 2010 guideline (some ways to improve its type I error control).  STATISTICS IN MEDICINE.  43(7):1475-1488. 2024
• A statistical analysis for the epidemiological surveillance of COVID-19 in Chile.  SIGNA VITAE.  18(2):19-30. 2022
• Bootstrapping regression models with locally stationary disturbances.  TEST.  30:341-363. 2021
• Controlling type I error in the reference-scaled bioequivalence evaluation of highly variable drugs.  PHARMACEUTICAL STATISTICS.  18(5):583-599. 2019
• Consumer's risk in the EMA and FDA regulatory approaches for bioequivalence in highly variable drugs.  STATISTICS IN MEDICINE.  35(12):1933-1943. 2016